CellaVision AB (CEVI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CellaVision AB (CEVI) has a cash flow conversion efficiency ratio of 0.058x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr51.43 Million ≈ $5.53 Million USD) by net assets (Skr887.58 Million ≈ $95.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CellaVision AB net asset quality index to measure how much of total assets are equity-financed.
CellaVision AB - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how CellaVision AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is CellaVision AB's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CellaVision AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CellaVision AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong PAK Corporation Co Ltd
SHE:300625
|
0.041x |
|
Beijing Haohan Data Technology Co. Ltd. A
SHG:688292
|
N/A |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
-0.424x |
|
Taiwan Steel Union Co Ltd
TW:6581
|
0.035x |
|
Grupo Traxión S.A.B. de C.V
MX:TRAXIONA
|
0.047x |
|
Zhejiang Talent Television&Film Co Ltd
SHE:300426
|
-0.598x |
|
Sinopec Oilfield Service Corporation
F:YIZH
|
0.098x |
|
Kenmec Mechanical Engineering Co Ltd
TWO:6125
|
0.081x |
Annual Cash Flow Conversion Efficiency for CellaVision AB (2006–2025)
The table below shows the annual cash flow conversion efficiency of CellaVision AB from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see CellaVision AB (CEVI) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr887.58 Million ≈ $95.52 Million |
Skr200.53 Million ≈ $21.58 Million |
0.226x | -7.13% |
| 2024-12-31 | Skr815.73 Million ≈ $87.79 Million |
Skr198.44 Million ≈ $21.36 Million |
0.243x | -11.28% |
| 2023-12-31 | Skr716.39 Million ≈ $77.09 Million |
Skr196.44 Million ≈ $21.14 Million |
0.274x | +28.15% |
| 2022-12-31 | Skr641.63 Million ≈ $69.05 Million |
Skr137.28 Million ≈ $14.77 Million |
0.214x | -27.22% |
| 2021-12-31 | Skr543.28 Million ≈ $58.47 Million |
Skr159.72 Million ≈ $17.19 Million |
0.294x | +77.58% |
| 2020-12-31 | Skr429.62 Million ≈ $46.23 Million |
Skr71.12 Million ≈ $7.65 Million |
0.166x | -54.22% |
| 2019-12-31 | Skr348.37 Million ≈ $37.49 Million |
Skr125.99 Million ≈ $13.56 Million |
0.362x | +41.78% |
| 2018-12-31 | Skr290.38 Million ≈ $31.25 Million |
Skr74.07 Million ≈ $7.97 Million |
0.255x | -30.10% |
| 2017-12-31 | Skr240.85 Million ≈ $25.92 Million |
Skr87.90 Million ≈ $9.46 Million |
0.365x | -1.73% |
| 2016-12-31 | Skr206.18 Million ≈ $22.19 Million |
Skr76.57 Million ≈ $8.24 Million |
0.371x | -22.55% |
| 2015-12-31 | Skr183.52 Million ≈ $19.75 Million |
Skr88.00 Million ≈ $9.47 Million |
0.480x | +82.35% |
| 2014-12-31 | Skr151.30 Million ≈ $16.28 Million |
Skr39.78 Million ≈ $4.28 Million |
0.263x | +27.77% |
| 2013-12-31 | Skr132.52 Million ≈ $14.26 Million |
Skr27.27 Million ≈ $2.93 Million |
0.206x | +123.68% |
| 2012-12-31 | Skr124.91 Million ≈ $13.44 Million |
Skr11.49 Million ≈ $1.24 Million |
0.092x | -63.77% |
| 2011-12-31 | Skr126.07 Million ≈ $13.57 Million |
Skr32.02 Million ≈ $3.45 Million |
0.254x | +151.39% |
| 2010-12-31 | Skr113.42 Million ≈ $12.21 Million |
Skr11.46 Million ≈ $1.23 Million |
0.101x | -63.28% |
| 2009-12-31 | Skr74.80 Million ≈ $8.05 Million |
Skr20.58 Million ≈ $2.21 Million |
0.275x | +896.24% |
| 2008-12-31 | Skr45.98 Million ≈ $4.95 Million |
Skr1.27 Million ≈ $136.67K |
0.028x | -91.68% |
| 2007-12-31 | Skr20.07 Million ≈ $2.16 Million |
Skr6.67 Million ≈ $717.37K |
0.332x | +519.92% |
| 2006-12-31 | Skr17.73 Million ≈ $1.91 Million |
Skr950.00K ≈ $102.24K |
0.054x | -- |
About CellaVision AB
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology la… Read more